Today we reported #earnings for the third quarter of 2026 and provided a business update.
Read the full press release here: bit.ly/4kCwY9s $ARDX
Read the full press release here: bit.ly/4kCwY9s $ARDX
Ardelyx
This account is verified because it's an official organization on X. Learn more@ardelyx
Translating Scientific Breakthroughs into Promise for Patients.
Community Guidelines: rb.gy/07ltg3
Community Guidelines: rb.gy/07ltg3
225 Following 1.8K Followers 897 Posts
Latest posts 5
Today we announced that we have fully enrolled ahead of schedule all patients in the Phase 3 ACCEL clinical trial for the treatment of chronic idiopathic constipation (CIC) in adults.
Read the full press release here: bit.ly/4f3UPeD
Read the full press release here: bit.ly/4f3UPeD
What a great week at @ASNKidney 2026!
Thank you to everyone who visited our booth, attended our presentations, and spent time with our team. From sharing new data to having thoughtful conversations with colleagues across the #nephrology community, it was a week full of meaningful connections.
Until next time, #KidneyWk!
Thank you to everyone who visited our booth, attended our presentations, and spent time with our team. From sharing new data to having thoughtful conversations with colleagues across the #nephrology community, it was a week full of meaningful connections.
Until next time, #KidneyWk!
More from Ardelyx at #KidneyWk!
Following our poster presentations at American Society of Nephrology Kidney Week, we’re sharing additional insight behind our latest research.
Take a closer look at the findings and read our full press release: bit.ly/4yFpKVJ
#Nephrology
Following our poster presentations at American Society of Nephrology Kidney Week, we’re sharing additional insight behind our latest research.
Take a closer look at the findings and read our full press release: bit.ly/4yFpKVJ
#Nephrology
Save the date! We will present third quarter 2026 financial results and a business update on Tuesday, November 3, 2026, at 4:30 p.m. via live webcast and conference call. Learn more: bit.ly/3TUakPf $ARDX
0:05